Skip to main content
About_

Founded by leaders with a track record in next-wave AI and drug discovery, the CHARM team is now focused on demonstrating the potential for its next generation menin inhibitors in the clinic.

Leadership Team

Gary D. Glick, Ph.D.

Executive Chair

Beverley Carr, D.Phil., M.B.A.

Chief Business Officer

Read Bio

Erkut Bahceci, M.D.

Chief Medical Officer

Laura Hare

Chief Operating Officer

Read Bio

Nick Edmunds, Ph.D.

Chief Development Officer

Read Bio

Board

Gary D. Glick, Ph.D.

Executive Chair

Read Bio

Nihal Sinha, M.D.

Investor Director
Read Bio

Rishi Gupta, J.D.

Investor Director
Read Bio

Matt McAviney, M.D.

Investor Director

Read Bio

Mahesh Kudari, M.D.

Investor Director

Read Bio

Briggs Morrison, M.D.

Non-Executive Director
Read Bio

Kim Blackwell

Non-Executive Director

Read Bio

Co-Founders

Laksh Aithani

Co-Founder

Read Bio

David Baker

Co-Founder

Read Bio

Investors

Transforming outcomes
for patients living with AML